Treatment Response and Tolerability of Pegylated Interferon-α Plus Ribavirin Combination Therapy in elderly Patients (≥ 65 years) With Chronic Hepatitis C in Korea

BACKGROUND: The prevalence of hepatitis C virus (HCV) infections in elderly patients has been increasing in a number of countries. A few reports concerning pegylated interferon-α (PEG-IFN-α)-based combination treatment in elderly chronic hepatitis C (CHC) patients have been published, with slightly...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Hyeong Il, Kim, In Hee, Jeon, Byung Jun, Lee, Seok, Kim, Seong Hun, Kim, Sang Wook, Lee, Seung Ok, Lee, Soo Teik, Kim, Dae Ghon
Format: Artigo
Idioma:Inglês
Publicat: Kowsar 2012
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3437453/
https://ncbi.nlm.nih.gov/pubmed/23008722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.6170
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars